New insights into epigenetic regulation of resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities

Programmed cell death protein 1(PD-1) is a type of immune-inhibitory checkpoint protein, which delivers inhibitory signals to cytotoxic T cells by binding to the programmed death ligand-1 (PD-L1) displayed on the surface of cancer cells. Antibodies blocking PD-1/PD-L1 interaction have been extensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Mengyuan, Liu, Miao, Yang, Hua, Küçük, Can, You, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667634/
https://www.ncbi.nlm.nih.gov/pubmed/36384676
http://dx.doi.org/10.1186/s40164-022-00356-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667634/
https://www.ncbi.nlm.nih.gov/pubmed/36384676
http://dx.doi.org/10.1186/s40164-022-00356-0

Ejemplares similares